In 2009, Jayadev and Stiglitz [1] proposed 'two ideas' to increase innovation and reduce pharmaceutical costs and prices. These were the use of value-based pricing and promoting public funding of clinical trials. Since then, NICE has tried and not yet succeeded to …
CITATION STYLE
Hill, S. R. (2015). Affordable innovation: future directions in pharmaceutical policy. Journal of Pharmaceutical Policy and Practice, 8(S1). https://doi.org/10.1186/2052-3211-8-s1-k1
Mendeley helps you to discover research relevant for your work.